| 000 | 01726 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515032626.0 | ||
| 264 | 0 | _c20060818 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0884-0431 | ||
| 024 | 7 |
_a10.1359/jbmr.060415 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBäckesjö, Carl-Magnus | |
| 245 | 0 | 0 |
_aActivation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cJul 2006 |
||
| 300 |
_a993-1002 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdipocytes _xcytology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcification, Physiologic _xdrug effects |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xcytology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNiacinamide _xpharmacology |
| 650 | 0 | 4 |
_aOsteoblasts _xcytology |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aPPAR gamma _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 | _aSirtuin 1 |
| 650 | 0 | 4 |
_aSirtuins _xmetabolism |
| 650 | 0 | 4 |
_aStilbenes _xpharmacology |
| 700 | 1 | _aLi, Yan | |
| 700 | 1 | _aLindgren, Urban | |
| 700 | 1 | _aHaldosén, Lars-Arne | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 21 _gno. 7 _gp. 993-1002 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1359/jbmr.060415 _zAvailable from publisher's website |
| 999 |
_c16406126 _d16406126 |
||